What are the effects of eflornithine tablets?

Eflornithine tablets (eflornithine) is an ornithine decarboxylase inhibitor, mainly used to treat certain types of cancer, especially patients with high-risk neuroblastoma (HRNB). Neuroblastoma is a malignant tumor that is common in children, especially those under the age of five. Treatment of this condition often requires a combination of multiple drugs, including chemotherapy, radiotherapy, and immunotherapy. However, for some patients, especially those at high risk who have partially responded to multiple treatments, eflornithine tablets provide a new treatment option to help reduce the risk of recurrence.

The mechanism of action of eflornithine is through inhibiting ornithine decarboxylase (ODC). ODC is an important enzyme for the synthesis of polyamines and is involved in cell proliferation and tumor growth. By inhibiting the activity of this enzyme, eflornithine can reduce the synthesis of polyamines, thereby inhibiting the growth and spread of tumor cells. In the treatment of neuroblastoma, eflornithine is typically used in patients who have had a partial response to multimodal treatments, including anti-GD2 immunotherapy, to reduce the risk of recurrence.

In addition to its effects on neuroblastoma, eflornithine is used to treat a number of other types of disease. For example, it has been used to treat African sleeping sickness caused by malaria parasites, and has also shown some efficacy in improving skin diseases such as hirsutism, especially facial hirsutism. Eflornithine can significantly reduce facial hair growth by altering the hormonal mechanism of hair growth.

Overall, eflornithine tablets are clinically used to reduce the risk of recurrence in patients with high-risk neuroblastoma, especially those who have a partial response to previous treatments. Eflornithine provides a new drug treatment option for delaying disease progression. In addition, its use in the treatment of sleep disorders and hirsutism in Africa demonstrates its broad therapeutic potential.

Reference materials:https://www.drugs.com/mtm/eflornithine.html